Stock Track | Elevance Health Plunges 5.57% in Pre-Market Despite Q2 Beat as Year-over-Year Earnings Decline and Profit-Taking Weigh

Stock Track

Jul 15

Elevance Health's stock experienced a significant pre-market plunge of 5.57% on Wednesday, following the release of its second-quarter financial results.

While the health insurer reported adjusted earnings per share of $7.45 for the quarter, surpassing the Wall Street consensus estimate of $6.21, this figure represented a 15.7% decline compared to the $8.84 reported in the same period last year. The company also raised its full-year adjusted EPS guidance to at least $27.00.

The sharp decline in pre-market trading is attributed to investor concerns over the year-over-year earnings contraction and profit-taking activity. The stock had rallied strongly in the prior session, surging approximately 5.25% in pre-market trading as several investment banks raised their price targets ahead of the earnings report, suggesting that the positive quarterly beat may have been partially anticipated by the market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1143864652"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143864652\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143864652?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143864652","market":"hk","top_or_hot":-1,"title":"Stock Track | Elevance Health Plunges 5.57% in Pre-Market Despite Q2 Beat as Year-over-Year Earnings Decline and Profit-Taking Weigh","media":"Stock Track","content":"<p>Elevance Health's stock experienced a significant pre-market plunge of 5.57% on Wednesday, following the release of its second-quarter financial results.</p><p>While the health insurer reported adjusted earnings per share of $7.45 for the quarter, surpassing the Wall Street consensus estimate of $6.21, this figure represented a 15.7% decline compared to the $8.84 reported in the same period last year. The company also raised its full-year adjusted EPS guidance to at least $27.00.</p><p>The sharp decline in pre-market trading is attributed to investor concerns over the year-over-year earnings contraction and profit-taking activity. The stock had rallied strongly in the prior session, surging approximately 5.25% in pre-market trading as several investment banks raised their price targets ahead of the earnings report, suggesting that the positive quarterly beat may have been partially anticipated by the market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Elevance Health Plunges 5.57% in Pre-Market Despite Q2 Beat as Year-over-Year Earnings Decline and Profit-Taking Weigh</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Elevance Health Plunges 5.57% in Pre-Market Despite Q2 Beat as Year-over-Year Earnings Decline and Profit-Taking Weigh\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-15 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Elevance Health's stock experienced a significant pre-market plunge of 5.57% on Wednesday, following the release of its second-quarter financial results.</p><p>While the health insurer reported adjusted earnings per share of $7.45 for the quarter, surpassing the Wall Street consensus estimate of $6.21, this figure represented a 15.7% decline compared to the $8.84 reported in the same period last year. The company also raised its full-year adjusted EPS guidance to at least $27.00.</p><p>The sharp decline in pre-market trading is attributed to investor concerns over the year-over-year earnings contraction and profit-taking activity. The stock had rallied strongly in the prior session, surging approximately 5.25% in pre-market trading as several investment banks raised their price targets ahead of the earnings report, suggesting that the positive quarterly beat may have been partially anticipated by the market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV","symbol_name":"Elevance Health","start_time":0,"source_url":"","article_id":"1143864652","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143864652","pubTimestamp":1784110997,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Elevance Health's stock experienced a significant pre-market plunge of 5.57% on Wednesday, following the release of its second-quarter financial results.While the health insurer reported adjusted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ELV":"Elevance Health"},"translate_title":"股票跟踪 | 尽管第二季度表现强劲，但由于盈利同比下降和获利回吐压力，Elevance Health 盘前仍暴跌 5.57%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"Elevance Health's stock experienced a significant pre-market plunge of 5.57% on Wednesday, following the release of its second-quarter financial results.While the health insurer reported adjusted earnings per share of $7.45 for the quarter, surpassing the Wall Street consensus estimate of $6.21, this figure represented a 15.7% decline compared to the $8.84 reported in the same period last year. The company also raised its full-year adjusted EPS guidance to at least $27.00.The sharp decline in pre-market trading is attributed to investor concerns over the year-over-year earnings contraction and profit-taking activity. The stock had rallied strongly in the prior session, surging approximately 5.25% in pre-market trading as several investment banks raised their price targets ahead of the earnings report, suggesting that the positive quarterly beat may have been partially anticipated by the market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}